TipRanks
Insulet (DE:GOV)
XETRA:GOV

Compare Insulet (GOV) vs. Competitors

5 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Insulet
€122.35
€8.30B
25.09
-56.28%
9 Buy
10 Hold
0 Sell
Moderate Buy
Abbott Laboratories
$116.13
$170.84B
31.67
-26.65%
14 Buy
0 Hold
0 Sell
Strong Buy
Dexcom
$88.96
$31.81B
32.59
24.54%
19 Buy
1 Hold
0 Sell
Strong Buy
Medtronic
$92.02
$109.38B
21.45
-10.34%
11 Buy
9 Hold
0 Sell
Moderate Buy
Tandem Diabetes Care
$21.37
$1.10B
-16.88
2.18%
8 Buy
7 Hold
0 Sell
Moderate Buy
Beta Bionics, Inc.
$19.07
$975.35M
-10.38
-21.24%
10 Buy
4 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:GOV
Insulet
119.10
-156.90
-56.85%
ABT
Abbott Laboratories
98.49
-31.81
-24.41%
DXCM
Dexcom
84.41
16.33
23.99%
MDT
Medtronic
87.75
-5.65
-6.05%
TNDM
Tandem Diabetes Care
15.68
0.86
5.77%
BBNX
Beta Bionics, Inc.
17.43
-4.80
-21.59%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts